title: The evolving war on cancer.
abstract: Building on years of basic scientific discovery, recent advances in the fields of cancer genetics and medicinal chemistry are now converging to revolutionize the treatment of cancer. Starting with serendipitous observations in rare subsets of cancer, a paradigm shift in clinical research is poised to ensure that new molecular insights are rapidly applied to shape emerging cancer therapies. Could this mark a turning point in the "War on Cancer"?
authors: Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA. haber@helix.mgh.harvard.edu
authors: Daniel A
authors: DA
authors: Haber
authors: Nathanael S
authors: NS
authors: Gray
authors: Jose
authors: J
authors: Baselga
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D035843:Biomedical Research / Q000191:economics*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents